Skip to main content
Log in

Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The objective of this work was to develop tablet formulations of nimesulide-β-cyclodextrin (NI-β-CD) and meloxicam-γ-cyclodextrin (ME-γ-CD) binary systems. In the case of nimesulide, 3 types of binary systems—physical mixtures, kneaded systems, and coevaporated systems—were studied. In the case of meloxicam, 2 types of binary systems—physical mixtures and kneaded systems—were investigated. Both drug-CD binary systems were prepared at 1∶1 and 1∶2 molar ratio (1∶1M and 1∶2M) and used in formulation studies. The tablet formulations containing drug-CD binary systems prepared by the wet granulation and direct compression methods showed superior dissolution properties when compared with the formulations of the corresponding pure drug formulations. Overall, the dissolution properties of tablet formulations prepared by the direct compression method were superior to those of tablets prepared by the wet granulation method. Selected tablet formulations showed good stability with regard to drug content, disintegration time, hardness, and in vitro dissolution properties over 6 months at 40°C±2°C and 75% relative humidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Duchene D, Wouessidjewe D. Pharmaceutical uses of cyclodextrins and derivatives.Drug Dev Ind Pharm. 1990;16:2487–2499.

    Article  CAS  Google Scholar 

  2. Bekers O, Uijtendal EV, Beijnen JH, Bult A, Underberg WJ. Cyclodextrins in pharmaceutical field.Drug Dev. Ind Pharm. 1991;17:1503–1549.

    Article  CAS  Google Scholar 

  3. Davis R, Brogden RN. Nimesulide: an update of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy.Drugs. 1994;48:431–454.

    Article  CAS  Google Scholar 

  4. Engelhardt G, Homma D, Schlegel K, Schnitzeler C, Utzmann R. Anti inflammatory, analgesic, antipyretic and related properties of meloxicam, a new nonsteroidal anti inflammatory agent with favourable gastrointestinal tolerance.Inflamm Res. 1995;44:423–433.

    Article  CAS  Google Scholar 

  5. Engelhardt G, Bogel R, Schnitzeler C, Utzmann R. Meloxicam: influence on arachidonic acid metabolism. Part 1: in vitro findings.Biochem Pharmacol. 1996;51:21–28.

    Article  CAS  Google Scholar 

  6. Churchill L, Graham AG, Shih CK, Pauletti D, Farina PR, Grob PM. Selective inhibition of human cyclooxygenase-2 by meloxicam.Inflammopharmacology. 1996;4:125–135.

    Article  CAS  Google Scholar 

  7. Pairet M, Engelhardt G. Differential inhibition of COX-1 and COX-2 in vitro and pharmacological profile in vivo of NSAIDs. In: Vane J, Botting J, Botting R, eds.Improved Nonsteroidal Anti-inflammatory Drugs-COX-2 Enzyme Inhibitors. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1996:103–119.

    Google Scholar 

  8. Distel M, Mueller C, Bluhmki E. Global analysis of gastrointestinal safety of a new NSAID, meloxicam.Inflammopharmacology. 1996;4:71–81.

    Article  CAS  Google Scholar 

  9. Turck D, Busch U, Heinzel G, Narjes H. Clinical pharmacokinetics of meloxicam.Arzneimittelforschung. 1997;47:253–258.

    CAS  Google Scholar 

  10. Piel G, Pirotte B, Delneuveille I, et al. Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes.J Pharm Sci. 1997;86:475–480.

    Article  CAS  Google Scholar 

  11. Nalluri BN, Chowdary KPR, Murthy KV, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems.AAPS PharmSciTech. 2003;4:E2. serial online.

    Article  Google Scholar 

  12. Naidu NB, Chowdary KP, Murthy KV, Satyanarayana V, Hayman AR, Becket G. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems.J Pharm Biomed Anal. 2004;35:75–86.

    Article  CAS  Google Scholar 

  13. Bodmeier R, Paerataku O. Constant potassium chloride release from microporous membrane-coated tablets prepared with aqueous colloidal polymer dispersions.Pharm Res. 1991;8:355–359.

    Article  CAS  Google Scholar 

  14. Khan KA. The concept of dissolution efficiency.J Pharm Pharmacol. 1975;27:48–49.

    CAS  Google Scholar 

  15. Carstensen JT. Stability and dating of solid dosage forms. In: Carstensen JT, ed.Pharmaceutics of Solids and Solid Dosage Forms. New York, NY: Wiley-Interscience; 1997:182–185.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter A. Crooks.

Additional information

Published: May 11, 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nalluri, B.N., Chowdary, K.P.R., Murthy, K.V.R. et al. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems. AAPS PharmSciTech 8, 36 (2007). https://doi.org/10.1208/pt0802036

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt0802036

Keywords

Navigation